ConductScience.org, home

Paper4150000

Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol.

Franciosa JA and 2 others. Circulation, 1973. Cited by 76 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol. Papers, record 4150000. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4150000

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol.
PubMed
Journal
Circulation
PubMed
Year
1973
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
76
iCite
Relative citation ratio, by iCite
4.61
iCite
Revised in PubMed
2019-06-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Franciosa JAJ A
2Freis EDE D
3Conway JJ

Source PubMed

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AntagonistsMajor topic
Amino AlcoholsMajor topic
Antihypertensive AgentsMajor topic
HemodynamicsMajor topic
Administration, Oral
Blood Pressure
Butylamines
Cardiac Output
Heart Rate
Humans
Hypertension
Male
Middle Aged
Morpholines
Propranolol
Thiadiazoles
Valsalva Maneuver
Vascular Resistance

Source PubMed

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.

PMIDTitleJournalYearIn PapersSource
29,767,982DenTimol as A Dendrimeric Timolol Analogue for Glaucoma Therapy: Synthesis and Preliminary Efficacy and Safety Assessment.Mol Pharm2018https://conductscience.org/library/papers/29767982PubMed
4,547,241Late results of aortocoronary bypass grafts in 100 patients with stable angina pectoris.Can Med Assoc J1974https://conductscience.org/library/papers/4547241PubMed
4,156,321Use of beta-adrenoreceptor blocking drugs in hypertension.Drugs1974https://conductscience.org/library/papers/4156321PubMed
4,156,320beta-adrenoreceptor blocking drugs in hypertension.Drugs1974https://conductscience.org/library/papers/4156320PubMed
1,679,662Influence of nebivolol on the cardiovascular hemodynamics during postural changes and isometric exercise.Cardiovasc Drugs Ther1991https://conductscience.org/library/papers/1679662PubMed
1,203,050Influence of the sympathomimetic activity of oxprenolol on haemodynamics in the anaesthetized dog.Basic Res Cardiol1975https://conductscience.org/library/papers/1203050PubMed
1,003,866[Effect of the beta-receptor-blocker prindolol on renal hypertension (author's transl)].Klin Wochenschr1976https://conductscience.org/library/papers/1003866PubMed
786,673Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.Eur J Clin Pharmacol1975https://conductscience.org/library/papers/786673PubMed
359,018Acebutolol in hypertension--double-blind trial against placebo.Br J Clin Pharmacol1978https://conductscience.org/library/papers/359018PubMed
237,770Potentiating effect of beta-adrenergic stimulant on the response of the cutaneous vascular resistance to alpha-adrenergic stimulant.Experientia1975https://conductscience.org/library/papers/237770PubMed
236,167Timolol: a preliminary report of its pharmacological properties and therapeutic efficacy in angina and hypertension.Drugs1975https://conductscience.org/library/papers/236167PubMed
40,797Blood pressure and plasma noradrenaline during single high-dose beta adrenoceptor blockade.Eur J Clin Pharmacol1979https://conductscience.org/library/papers/40797PubMed
23,284Antihypertensive drugs: clinical pharmacology and therapeutic use.Drugs1977https://conductscience.org/library/papers/23284PubMed
6,245Haemodynamic effects of beta-adrenorecptor blockers in hypertension.Drugs1976https://conductscience.org/library/papers/6245PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4150000

GET https://conductscience.org/api/papers/v1/4150000/authors